Will These Small Cap Marijuana Stocks Get Investors High? ICBU, TAUG, MLCG & LXRP

Small cap marijuana stocks IMD Companies Inc (OTCMKTS: ICBU), Tauriga Sciences Inc (OTCMKTS: TAUG), ML Capital Group Inc (OTCBB: MLCG) and Lexaria Corp (OTCMKTS: LXRP) are aiming to give investors a high with their latest news. However, only one of these small cap marijuana stocks appears to be the subject of minor paid promotion or investor relations type of activities. So will investors and traders alike get a high off of these small caps? Here is a quick reality check:

IMD Companies Inc (OTCMKTS: ICBU) Has a Funding Commitment for Over $1 Million

Small cap IMD Companies is a Florida corporation, engaged in the medical diagnostics and health and fitness industries. The company is currently positioned to be a holding company for major acquisitions in the medical, and marijuana industry. On Friday, IMD Companies rose 7.82% to $0.120 for a market cap of $19.35 million plus ICBU is up 264.7% over the past year and up 23,900% over the past five years according to Google Finance.

What's the Catch With IMD Companies Inc? According to various disclosures, no transactions have occurred to mention IMD Companies in various investment newsletters. Last Thursday, IMD Companies announced that it had agreed to a private placement investment with Irwin "Izzy" Zalcberg, a "well-known distinguished accredited Small Cap investor with a large rolodex of connections in the upper echelon of the corporate world." IMD Companies has already received the first round of investment from Izzy with the total commitment being just over $1,000,000.00 plus he has verbally committed additional funds if the company has the "need of them for future acquisitions or joint ventures." On Wednesday, IMD Companies announced that it had successfully implemented a network interface into its environmental controller, the EMC-5000, which will allow users to monitor their grow rooms remotely from a laptop or desktop and then make changes to their grow room settings as well as monitor all other aspects of the environment. Otherwise and during the previous week, IMD Companies announced it had hired Jim Filkins, who has over 25 years of experience bringing products to the market place, both in North America and internationally, as Vice President of Sales. A quick look at IMD Companies's financials reveals revenues of $92k (most recent reported quarter), $134k, $103k and $111k for the past four reported quarters along with net losses of zero (most recent reported quarter), $236k and $56k and net income of $178k. At the end of last September, IMD Companies had $2k in cash to cover $92k in current liabilities and $1,028k in long term debt. So at least IMD Companies has found a benefactor in the form of "Izzy."

Tauriga Sciences Inc (OTCMKTS: TAUG) Makes an Acquisition

Small cap Tauriga Sciences is a diversified company focused on generating profitable revenues through license agreements and the development of a proprietary technology platform in the nano-robotics space. On Friday, Tauriga Sciences rose 2.82% to $0.091 for a market cap of $47.59 million plus TAUG is down 1.1% over the past year and down 9% over the past five years according to Google Finance.

What's the Catch With Tauriga Sciences Inc? According to various disclosures, no transactions have occurred to mention Tauriga Sciences in various investment newsletters. Last Friday, Tauriga Sciences announced it had entered into a definitive merger agreement (on March 11, 2014) with Oakland, California based Honeywood LLC, an affiliate of Doc Green's Healing Collective which has been researching and developing cannabis based healing products since 2010. Honeywood's main business models and industry capabilities include: the ability to manufacture medicinal Cannabis based products, the licensing of brands and delivery technologies, and the infrastructure to provide laboratory services to the medicinal cannabis industry. Honeywood LLC generates revenues through the development of proprietary formulations like Doc Green's Therapeutic Healing Cream (www.docgreens.org), is currently focused on increasing its capacity to produce and develop products and is actively pursuing intra-state expansion opportunities in the 27 states. On Tuesday, Tauriga Sciences announced the appointment of Alan H. Vicory Jr. PE, BCEE as the fourth member of the company's scientific advisory board. Otherwise and in early March, Tauriga Sciences announced the execution of a non-binding term sheet of up to $1,000,000 to fund a proposed acquisition of California's leading manufacturer of topical and medicinal cannabis products with the final terms between the company and the institutional investor to be disclosed in a to-be-finalized binding agreement. A quick look at Tauriga Sciences' financials reveals no revenues; net losses of $1,599k (most recent reported quarter), $1,439k, $2,451k and $2,939k for the past four reported quarters; and $58k in cash to cover $1,387k in current liabilities at the end of last year. So investors might want to wait for this quarters financials to appear before getting overly excited.

ML Capital Group Inc (OTCBB: MLCG) Is Launching the SuperStar Vapor Pen

Small cap ML Capital Group's primary business consists of providing management, financial and strategic consulting services designed to advance and improve an organization's ability to conduct its business more effectively and to foster sales growth, with a principal focus on assisting companies in the green technology industry as well as produces, markets and sells its own branded products that are specifically focused on the medical marijuana, or "green medicine," industry. On Friday, ML Capital Group closed at $0.105 for a market cap of $6.44 million plus MLCG is down 89.6% since June 2013 according to Google Finance.

What's the Catch With ML Capital Group Inc? According to various disclosures, no transactions have occurred to mention ML Capital Group in various investment newsletters. Last Thursday, the ML Capital Group announced that it had signed its first major distributor to market and sell the SuperStar Vapor Pen. The distributor is the New York Merv Marketing Group and will concentrate its initial efforts in securing numerous points of sale for the SuperStar Vapor Pen through established specialty retail stores and nationally recognized convenience stores throughout the New York metropolitan area. Otherwise and on Tuesday, the ML Capital Group issued a press release to remind investors it had completed the design and packaging of its initial SuperStar Vapor Pen product line along with the near term completion of its SuperStar MMJ Dispensaries smartphone application. The press release then said it had completed writing a new medical marijuana recipe book that is going through final editing. A quick look on Google Finance at ML Capital Group's financials reveals no revenues; net losses of $0.18M (most recent reported quarter), $0.09M, $1.38M and $0.01M for the past four reported quarters; and no cash to cover $0.06M in current liabilities at the end of last June. So investors might want to wait for some updated financials that also reflect its activities in the marijuana sector.

Lexaria Corp (OTCMKTS: LXRP) Is Entering the Marijuana Business Through a Joint Venture

Small cap Lexaria Corp searches for projects that could provide potential above-market returns. On Friday, Lexaria Corp fell 3.17% to $0.610 for a market cap of $10.33 million plus LXRP is up 916.7% over the past year and up 713.3% over the past five years according to Google Finance.

What's the Catch With Lexaria Corp? According to various disclosures, a transaction or transactions of $1k has or will occur to mention Lexaria Corp in various investment newsletters. Last Friday, Lexaria Corp announced it had closed its Private Placement financing announced on March 5 for gross proceeds of $1,272,000 – higher than the originally announced $960,000 figure due to "overwhelming demand." Lexaria Corp will issue 10,600,000 common shares at US$0.12 and 10,600,000 full warrants that expire on September 21, 2016 with an exercise price of US$0.25. However, the company may also accelerate the expiry date of the warrants if the stock price trades above CAD$0.40 cents for 20 consecutive days at any time after 6 months and one day has elapsed. Otherwise and in early March, Lexaria Corp reported that its board of directors had decided to make a strategic entry into the medical marijuana business by way of an "important Joint Venture" with Enertopia Corp (OTCQB: ENRT). Under the terms of the Agreement, Lexaria Corp had agreed to pay Enertopia 1 million restricted common shares in return for Enertopia's participation plus 500,000 restricted common shares ENRT's Chairman in return for his participation on the Lexaria Advisory Board. Following the issuance of these shares, Lexaria Corp will have a total of 18,431,452 shares issued and outstanding and 21,256,452 shares fully diluted. A quick look at Lexaria Corp's financials reveals revenues of $160k (most recent reported quarter), $241k, $251k and $253k for the past four quarters along with net losses of $102k (most recent reported quarter), $126k, $58k and $48k. At the end of last January, Lexaria Corp had $66k in cash to cover $1,415k in current liabilities and $59k in other liabilities. So aside from the income statement, investors might want to look more closely at Lexaria Corp's financing terms.